NASDAQ | ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index.
The index includes common stocks and depositary receipts ofU. S. exchange-listed companies in the pharmaceutical industry.
Such companies may include medium-capitalization companies and foreign companies that are listed on aU. S. exchange.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 18.53% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 10.15% |
| NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 7.65% |
| NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 7.55% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.78% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 4.64% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 4.50% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.40% |
| ABC | AmerisourceBergen | Healthcare | Medical Distribution | 4.39% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.36% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.35% |
| GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 4.29% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.85% |
| H6D | Haleon PLC | 3.51% | ||
| TAK | Takeda Pharmaceutical Co Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 2.88% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 1.57% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.23% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.67% |